Securities Code: 301371
Securities Abbreviation: Furenjia
Announcement Number: 2026-033
Harbin Furenjia Technology Co., Ltd.
Announcement on Acceptance of Medical Device Registration Certificate Application
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Harbin Furenjia Technology Co., Ltd. (hereinafter referred to as the "Company") announced on February 24, 2026, the "Announcement on the Completion of Clinical Trials for Class III Medical Device Products" (Announcement Number: 2026-002). The Company's research and development product, "Recombinant Humanized Collagen Type III Freeze-Dried Fiber," has completed clinical trials and obtained a clinical trial summary report, enabling the submission of registration application materials.